Stockholm (Reuters)-US private-equity fund Advent International and Singapore’s sovereign wealth fund announced on Friday that they would withdraw their bids on Swedish pharmaceutical company Orphan Biobitrum (Sobi).
In September, Sobi agreed to acquire Agnafit Bidco for $ 8 billion by Advent and Aurora, investment vehicles of GIC Pte Ltd in Singapore.
“Agnafit Bidco withdraws the offer here because the acceptance level requirements are not met,” Agnafit Bidco said in a statement.
According to Agnafit, about 87.3% of Sobi’s outstanding shares have been bid, below the 90% or higher requirement.
Fusion media Alternatively, anyone involved with Fusion Media will not be liable for any loss or damage resulting from reliance on the data, quotes, charts, trading signals and other information contained on this website. Be fully informed about the risks and costs associated with financial market transactions. This is one of the most risky forms of investment possible.
Advent withdraws $ 8 billion bid for Swedish pharmaceutical company Soviet by Reuters
Source link Advent withdraws $ 8 billion bid for Swedish pharmaceutical company Soviet by Reuters